Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors

Fig. 1

Mutation spectra of uterine smooth muscle tumors. The frequencies of MED12 mutations, HMGA2 aberrations, and biallelic FH inactivation in conventional ULs a, histopathological UL variants b-e, and ULMSs f. Eleven mitotically active leiomyomas with increased cellularity were included in both mitotically active and cellular/highly cellular leiomyoma subtypes

Back to article page

Molecular Cancer

ISSN: 1476-4598